Clinical trial
A Post-Approval Study of the RotablatorTM Rotational Atherectomy System in China
NCT03806621 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-Approval Study of the RotablatorTM Rotational Atherectomy System in China
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 18, 2018
- Completion date
- January 20, 2022
- Enrollment
- 980 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.